Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00129493 · ClinicalTrials.gov registry record · NA

Group Visits to Improve Hypertension Management

A NA study of Hypertension, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
300
Enrollment target
2
Study locations

NCT00129493: Completed NA study of Hypertension, sponsored by US Department of Veterans Affairs.

NCT00129493 is a NA study of Hypertension that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 300 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00129493, a NA study of Hypertension, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
300 participants
Enrollment target
2
Study locations

Study Summary

This study investigates group medical visits as a quality improvement strategy for hypertension. It studies group visits in which patients see their own primary care provider together with other patients who have hypertension. The group visits are intended to enhance the patient's self-efficacy for self-management of their chronic disease (hypertension).

Conditions Studied

Interventions

  • BEHAVIORAL Group medical visits

Study Locations (2)

California

  • VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto

Massachusetts

  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2004-02
Est. Completion 2007-08
Phase NA
US Department of Veterans Affairs

632 total trials

What the finished NCT00129493 record still lists

NCT00129493 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Group medical visits is the first listed.

NCT00129493 reports a single indexed study location in California, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00129493 about?

NCT00129493 is a clinical study titled "Group Visits to Improve Hypertension Management". This study investigates group medical visits as a quality improvement strategy for hypertension. It studies group visits in which patients see their own primary care provider together with other patients who have hypertension. The group visits are intended to enhance the patient's self-efficacy for ...

What is the current status of trial NCT00129493?

This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2004-02. Estimated completion is 2007-08.

What conditions does trial NCT00129493 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT00129493?

The interventions under investigation include: Group medical visits (BEHAVIORAL).

Who is sponsoring clinical trial NCT00129493?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00129493 being conducted?

This trial has 2 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00129493's enrollment target sits among peer trials

300 170th of 470 higher than 291 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00129493, the US trial registry maintained by the National Library of Medicine. NCT00129493 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.